Lipid levels and risk-stratified management gaps of dyslipidemia in China
{{output}}
Background: Dyslipidemia remains a major modifiable contributor to China's cardiovascular disease (CVD) burden, yet large-scale evidence on risk-stratified management gaps is lacking. ... ...
